FGF9 and breast carcinoma: Other studies have reported involvement of both miRNAs in human malignant tumors through the targeted downregulation of a number of genes including fibroblast growth factor 9 [44], dickkopf WNT signaling pathway inhibitor 1 [45], and others [46–48], and miR-372-3p was shown to promote epithelial mesenchymal transition in breast carcinoma through WNT pathway activation [46].